Chikungunya virus (CHIKV; family *Togaviridae*; genus *Alphavirus*) is an arthropod-borne virus transmitted to humans by *Aedes* spp. mosquitoes ([@R1]). It is an enveloped, positive-sense, single-stranded RNA virus with a genome of ≈11.8 kb ([@R2]). Three genotypes have been identified: Western African, East Central South African (ECSA), and Asian ([@R3]).

First identified in Tanzania in the mid-1950s, CHIKV circulated in the 1960s in sub-Saharan Africa and several Asian countries ([@R4],[@R5]). Reemergence of CHIKV (ECSA genotype) was reported in Democratic Republic of Congo in 1999--2000 ([@R6],[@R7]) and in Kenya in 2004 ([@R4]). This genotype emerged in Comoros followed by Réunion Island, the Seychelles, Mauritius, Mayotte, and India in 2005 (the Indian Ocean outbreak); in Sri Lanka and Malaysia in 2006; in Singapore and Thailand in 2008; and in China in 2010 ([@R8]).

In Cambodia, CHIKV was first detected in 1961, probably the Asian genotype that was circulating in the region at that time ([@R9]). Since 2000, all blood specimens collected by the National Dengue Control Program, Ministry of Health Cambodia, during hospital-based surveillance of dengue and investigation of suspected dengue cases have been screened for IgM against CHIKV, dengue virus (DENV), Japanese encephalitis virus (JEV), and other arboviruses. Despite this testing, no evidence of acute or recent CHIKV infections has been found. To confirm CHIKV infection in samples positive by serologic testing, we conducted real-time reverse transcription PCR (RT-PCR) and complete genome sequencing of the samples. In 2011, we detected CHIKV ECSA genotype in patients in Cambodia and analyzed the phylogenetic origin of the strains.

The Study
=========

We obtained samples from 3 sources: national dengue-like surveillance, an encephalitis study, and the outbreak investigation. From surveillance, during 2000--2011, an average of \>700 paired serum samples were collected annually from patients admitted to sentinel hospitals for dengue-like syndrome (Battambang, Siem Reap, Kampong Cham, Takeo, Phnom Penh; [Figure 1](#F1){ref-type="fig"}) in the National Dengue Control Program ([@R10]). From the encephalitis study, conducted July 2010 through July 2011, samples from 196 patients were collected as part of a surveillance study of central nervous system infections in Jayavarman VII hospital in Siem Reap (with written consent from patients or legal guardians and study approval by the National Ethics Committee in Cambodia). During the outbreak investigation, serum was collected during investigations by National Health authorities in Preah Vihear Province on August 16 (n = 9) and December 9--10, 2011 (n = 8), of outbreaks of suspected measles-like or dengue-like illnesses ([Table](#T1){ref-type="table"}).
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###### Characteristics of 24 patients with positive results for chikungunya virus, Cambodia, 2011\*

  Patient no.   Project   Age, y/sex   Date of symptom onset   Date sampled   Province   Initial syndrome reported   IgM-capture ELISA         RT-PCR   Full-genome sequencing         
  ------------- --------- ------------ ----------------------- -------------- ---------- --------------------------- ------------------- ----- -------- ------------------------ ----- ----------
  V0603308      NDCP      2/M          May 26                  May 28         BTB        Dengue†                     Neg                 Pos            Pos                      Pos   Partial
  V0603310      NDCP      4/F          May 26                  May 28         BTB        Dengue                      Neg                 Pos            Pos                      Pos   Complete
  V0705309      CNS       5/M          Jun 23                  Jun 30         SRP        Encephalitis‡               Neg                 Pos            Neg                      Neg   ND
  V0719309      CNS       14/M         Jul 9                   Jul 17         SRP        Encephalitis                Pos                 Pos            Neg                      Neg   ND
  V0719310      CNS       7/M          Jul 10                  Jul 13         KTH        Encephalitis                Pos                 Pos            Pos                      Neg   ND
  V1005304      NDCP      15/M         Sep 30                  Oct 4          KCH        Dengue                      Neg                 Pos            Pos                      Pos   ND
  V1024306      CDC       11/F         Aug 10                  Aug 16         PVH        Measles§                    Neg                 NA             Pos                      Neg   Complete
  V1024307      CDC       11/F         Aug 15                  Aug 16         PVH        Measles                     Pos                 NA             Neg                      Neg   ND
  V1024308      CDC       28/F         Aug 8                   Aug 16         PVH        Measles                     Neg                 NA             Pos                      Neg   Complete
  V1024309      CDC       30/F         Aug 8                   Aug 16         PVH        Measles                     Pos                 NA             Pos                      Pos   ND
  V1024310      CDC       17/M         Aug 13                  Aug 16         PVH        Measles                     Neg                 NA             Pos                      Pos   Complete
  V1024311      CDC       2.5/F        Aug 16                  Aug 16         PVH        Measles                     Neg                 NA             Pos                      Pos   Complete
  V1024312      CDC       13/F         Aug 16                  Aug 16         PVH        Measles                     Neg                 NA             Pos                      Pos   ND
  V1024313      CDC       10/F         Aug 14                  Aug 16         PVH        Measles                     Neg                 NA             Pos                      Pos   Complete
  V1024314      CDC       31/F         Aug 15                  Aug 16         PVH        Measles                     Neg                 NA             Pos                      Pos   Complete
  V1214306      NMC       49/M         Dec 9                   Dec 9          PVH        Dengue                      Neg                 NA             Pos                      Neg   ND
  V1214307      NMC       56/M         Dec 6                   Dec 9          PVH        Dengue                      Neg                 NA             Pos                      Neg   ND
  V1214308      NMC       29/M         Dec 5                   Dec 9          PVH        Dengue                      Neg                 NA             Pos                      Pos   ND
  V1214309      NMC       39/F         Dec 9                   Dec 10         PVH        Dengue                      Neg                 NA             Pos                      Pos   ND
  V1214310      NMC       17/F         Dec 9                   Dec 10         PVH        Dengue                      Neg                 NA             Pos                      Pos   ND
  V1214311      NMC       27/M         Dec 7                   Dec 10         PVH        Dengue                      Pos                 NA             Neg                      Neg   ND
  V1214312      NMC       16/M         Dec 9                   Dec 10         PVH        Dengue                      Neg                 NA             Pos                      Pos   ND
  V1214333      NMC       30/F         NA                      Dec 10         PVH        Dengue                      Neg                 NA             Pos                      Pos   ND
  V1207304      NDCP      9/F          Dec 1                   Dec 6          KAN        Dengue                      Pos                 Pos            Neg                      Neg   ND

\*All patients had negative IgM-capture ELISA results for flaviviruses (dengue 1--4, Japanese encephalitis, Langat) and other alphaviruses (Sindbis).  RT-PCR, real-time reverse transcription PCR; 1st, acute-phase serum sample; 2nd, convalescent-phase serum sample; SN, supernatant; NDCP: National Dengue Control Program, National Malaria Center, Ministry of Health; BTB, Battambang; Neg, negative; Pos, positive; CNS, central nervous system infection (encephalitis) study; SRP: Siem Reap; ND, not done; KTH: Kampong Thom; KCH: Kampong Cham; CDC, Communicable Disease Control Department, Ministry of Health, Preah Vihear outbreak investigation in August 2011; PVH: Preah Vihear; NA, not available; NMC, National Malaria Center, Ministry of Health, Preah Vihear outbreak investigation in December 2011; KAN, Kandal. †Dengue-like: fever with headache, retro-orbital pain, myalgia, joint pain, and/or hemorrhage. ‡Encephalitis: fever with convulsion, vomiting, and/or hemiplegia. §Measle-like: fever with rash, cough, or join pain.

All serum was tested at the Institut Pasteur in Cambodia. Acute-phase and/or convalescent-phase specimens were tested for IgM against flaviviruses (DENV, JEV, and Langat virus) and alphaviruses (CHIKV Ross C 347 strain and Sindbis virus). We used in-house IgM-capture ELISA as described by Vong et al. ([@R11]) with JEV, Langat, Sindbis, DENV, and CHIKV antigens; CHIKV was isolated by use of a mosquito cell line (clone C6/36 of *Aedes albopictus* cells) ([@R11]). Viral RNA was extracted from 140 µL of serum by using the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany) according to manufacturer's recommendations. The presence of CHIKV RNA was determined by real-time RT-PCR selective for the *E1* gene, according to a protocol adapted from Pastorino et al. ([@R12]) for a different Taq polymerase kit (SuperScript III Platinum One-Step Quantitative RT-PCR kit; Invitrogen, Carlsbad, CA, USA). Each series of tests included a negative control.

Among 19 samples positive for CHIKV by real-time RT-PCR, 8 were selected for complete genome sequencing. A total of 22 overlapped PCR products were obtained by using primers published by Schuffenecker et al. ([@R13]) and sent to Macrogen (Seoul, South Korea) for sequencing.

Sequence assembly and alignment were performed by using the CLC Main Workbench 5.5 package (CLC bio A/S, Aarhus, Denmark). The complete coding region (11,319 nt) of 8 CHIKV isolates from Cambodia were aligned with 64 reference strains available in GenBank. Phylogenetic analysis was performed by using the maximum-likelihood approach incorporating the GTR+Γ4 model of nucleotide substitution with a bootstrap resampling process of 1,000 replications.

During this reemergence of CHIKV in 2011, a total of 24 patients with fever, sometimes associated with acute arthritis or encephalitis (suggesting that many classical infections were not reported because encephalitis is a rare complication of chikungunya), had positive RT-PCR and/or IgM-capture ELISA results for CHIKV. The first 2 cases were identified in May 2011 by the National Dengue Control Program in Battambang Province (eastern Cambodia) near the Thailand border ([Figure 1](#F1){ref-type="fig"}). These 2 cases were in children hospitalized for suspected dengue. Subsequent cases were reported the same year in Siem Reap (2 cases, June and July), Kampong Thom (1 case, July), Kampong Cham (1 case, October), and Kandal (1 case, December) Provinces. Two other outbreaks were documented in villages in Preah Vihear Province (northern Cambodia) in August (9 cases) and December (8 cases) 2011 ([Table](#T1){ref-type="table"}). The sequence of outbreaks, in time and space, suggests that the virus was introduced to areas bordering Thailand and progressed through Cambodia, affecting city and villages along major northwest to southeast routes ([Figure 1](#F1){ref-type="fig"}). Average patient age was 20 years (range 2--56 years); cases were distributed equally among male and female patients.

Conclusions
===========

The alignment of the *E1* gene sequence of CHIKV showed that all 8 strains carried the same amino acid substitution in the E1 protein (E1-A226V) as did the strains that were naturally selected by the mosquito vector a few months after the beginning of the Indian Ocean outbreak ([@R13]). Phylogenetic analysis of the complete genome sequence revealed that all viruses from Cambodia clustered with those isolated during the Indian Ocean outbreak and within the ECSA phylogenetic group ([Figure 2](#F2){ref-type="fig"}). These isolates from Cambodia were closely related to the viruses isolated from southern Thailand during the 2008--2009 outbreak with bootstrap values \<70 (data not shown) and to other isolates from the recent outbreaks in Asia (Singapore, Malaysia, Indonesia, and China). The pairwise nucleotide comparison of the complete coding region showed a high average percentage of similarity (\>99.50%) with the recent isolates from Thailand, Malaysia, Singapore, and China. The identity between the strains from Cambodia ranged from 99.89% to 99.93% at the nucleotide level. Of note, the Cambodian strains can be separated into 2 groups supported by a bootstrap value of 100, suggesting that the viruses isolated in Battambang and Preah Vihea Provinces, which each border Thailand, could have been introduced separately, although we cannot exclude the possibility of introduction from other Asian countries as well.
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As numbers of reported cases, numbers of provinces affected, and abundance of mosquito vectors (*Ae. aegypti* and *Ae. albopictus*) increase, the risk for local transmission will probably increase in the next few years, and levels of CHIKV infection could reach those of DENV infection. The ECSA genotype could then become endemic to Cambodia, which could face the same situation as in the 1960s, when a number of chikungunya cases were reported in Cambodia, although the 1960s epidemic did not last long (according to data available) and was not followed by continuous virus circulation leading to successive outbreaks. As CHIKV reemerges after 50 years of absence or low-level transmission, cocirculation with DENV might cause substantial challenges for public health, especially hospital overloading and increased needs for case management. This outbreak of CHIKV ECSA genotype spread rapidly in Cambodia over a short 7-month period. The outbreak should serve as a warning for health authorities to prepare, not only in Cambodia, but also in other areas where, to our knowledge, this genotype has not been reported, such as Vietnam and Lao People's Democratic Republic.
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